SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/13/20 Lilly Endowment Inc SC 13G/A 1:64K Armata Pharmaceuticals, Inc. Broadridge Fin’l… Inc/FA |
Document/Exhibit Description Pages Size 1: SC 13G/A Amendment to Statement of Acquisition of HTML 43K Beneficial Ownership by a Passive Investor
Schedule 13G |
CUSIP No. | 532457-10-8 |
1 | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) | ||||
LILLY ENDOWMENT INC | |||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
INSTRUCTIONS) | ||||
(a) o | |||||
(b) o | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Indiana | |||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: | 5 | SOLE VOTING POWER | |||
114,560,599 | |||||
6 | SHARED VOTING POWER | ||||
0 | |||||
7 | SOLE DISPOSITIVE POWER | ||||
114,560,599 | |||||
8 | SHARED DISPOSITIVE POWER | ||||
0 | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
114,560,509 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
11.9% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
CO | |||||
FOOTNOTES | |||||
The percent of class represented is based on 960,130,771 shares of common stock outstanding as of October 21, 2019, as reported on the Issuer’s Form 10 Q for the period ended September 30, 2019. |
This statement is filed by Lilly Endowment Inc., a not for profit corporation organized under the laws of the State of Indiana. Lilly Endowment Inc. is an organization described in Section 501(c)(3) of the Internal Revenue Code of 1986 and is a private foundation under Section 509(a) of the Code. |
The address of the principal business office of Lilly Endowment Inc. is 2801 North Meridian Street, Indianapolis, Indiana 46208. |
(d) | o | Investment
company registered under section 8 of the Investment Company Act of 1940 (15
U.S.C 80a-8). |
(h) | o | A
savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813); |
(i) | o | A
church plan that is excluded from the definition of an investment company under
section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
(k) | o |
A group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify
the type of institution:
|
Lilly Endowment, Inc. | |||
Date:
January 07, 2020 | By:
| /s/ Diane M. Stenson | |
Name: Diane M. Stenson | |||
Title: Vice President & Treasurer | |||
Footnotes: | Item 4: This information is provided as of December 31, 2019.
Item 4(a): None of such shares are deemed to be beneficially owned by reason of the possession of Lilly Endowment Inc. of a right to acquire such shares. Item 4(b): The percent of class represented is based on 960,130,771 shares of common stock outstanding as of October 21, 2019, as reported on the Issuer’s Form 10 Q for the period ended September 30, 2019. |
This ‘SC 13G/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Changed on / Deleted on: | 4/1/20 | 4, S-3 | ||
Filed on: | 1/13/20 | 13F-HR, 4 | ||
1/7/20 | 4 | |||
12/31/19 | 10-K, 13F-HR, 5 | |||
10/21/19 | ||||
9/30/19 | 10-Q, 13F-HR | |||
List all Filings |